Other analysts have also recently issued reports about the company. Zacks Investment Research raised Xylem from a hold rating to a buy rating and set a $79.00 price objective on the stock in a report on Monday, February 4th. Oppenheimer set a $80.00 price objective on Xylem and gave the stock a buy rating in a report on Monday, February 4th. BMO Capital Markets reaffirmed a buy rating and set a $85.00 price objective on shares of Xylem in a report on Monday, February 25th. Janney Montgomery Scott cut Xylem from a buy rating to a neutral rating in a report on Friday, March 29th. Finally, Stifel Nicolaus upped their price objective on Xylem from $80.00 to $93.00 and gave the stock a buy rating in a report on Tuesday, April 16th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company. The company presently has an average rating of Buy and a consensus price target of $79.64.
Shares of XYL opened at $82.18 on Tuesday. The company has a market cap of $14.69 billion, a PE ratio of 28.53, a PEG ratio of 1.43 and a beta of 1.14. Xylem has a 1 year low of $60.65 and a 1 year high of $83.76. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.08 and a current ratio of 1.51.
Xylem (NYSE:XYL) last issued its quarterly earnings data on Thursday, January 31st. The industrial products company reported $0.88 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.88. The business had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Xylem had a return on equity of 19.89% and a net margin of 10.54%. As a group, equities analysts forecast that Xylem will post 3.31 EPS for the current fiscal year.
In related news, insider Tomas Brannemo sold 559 shares of the stock in a transaction on Thursday, February 21st. The stock was sold at an average price of $74.44, for a total transaction of $41,611.96. Following the sale, the insider now owns 10,568 shares in the company, valued at approximately $786,681.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven R. Loranger sold 10,000 shares of the stock in a transaction on Friday, March 15th. The shares were sold at an average price of $76.99, for a total value of $769,900.00. Following the sale, the director now owns 26,744 shares in the company, valued at approximately $2,059,020.56. The disclosure for this sale can be found here. Insiders have sold a total of 80,195 shares of company stock worth $6,000,933 in the last 90 days. 0.85% of the stock is currently owned by insiders.
Large investors have recently added to or reduced their stakes in the stock. BNP Paribas Arbitrage SA grew its position in Xylem by 3.8% in the 1st quarter. BNP Paribas Arbitrage SA now owns 176,559 shares of the industrial products company’s stock valued at $13,955,000 after acquiring an additional 6,527 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. grew its position in Xylem by 484.9% in the 1st quarter. Los Angeles Capital Management & Equity Research Inc. now owns 134,977 shares of the industrial products company’s stock valued at $10,669,000 after acquiring an additional 111,900 shares during the last quarter. Creative Planning grew its position in Xylem by 13.3% in the 1st quarter. Creative Planning now owns 20,292 shares of the industrial products company’s stock valued at $1,604,000 after acquiring an additional 2,378 shares during the last quarter. Oppenheimer Asset Management Inc. grew its position in Xylem by 3.2% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 25,940 shares of the industrial products company’s stock valued at $2,050,000 after acquiring an additional 806 shares during the last quarter. Finally, Gilman Hill Asset Management LLC grew its position in Xylem by 7.1% in the 1st quarter. Gilman Hill Asset Management LLC now owns 3,750 shares of the industrial products company’s stock valued at $296,000 after acquiring an additional 250 shares during the last quarter. Institutional investors own 86.90% of the company’s stock.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
See Also: Mutual Funds
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.